Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05851859

Evaluation of the Effectiveness of Breathing Control Technique on Long COVID Symptoms at the Reunion University Hospital

Despite the controversy, on October 6, 2021, the World Health Organization (WHO) recognized Long Coronavirus disease (COVID) by officially defining it: " symptoms appeared 3 months after the onset of the primary infection by the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), persisting for at least 2 months and which cannot be explained by any other condition ". Long COVID can affects any type of patient and has polymorphic and fluctuating symptoms over time.

The Reunion Island is a French overseas department located in the Indian Ocean accounting more than 860,000 inhabitants. It has recorded since March 11, 2020, nearly 491,825 cases of COVID-19 and 961 deaths of hospitalized patients. Reunion's population is multi-ethnic and younger than the metropolitan France's one. It also has a higher prevalence of obesity and type 2 diabetes, two serious form factors of COVID-19. This specific context makes this island a particular study site for Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) and Long COVID.

In addition, some studies have confirmed the involvement of the autonomic nervous system (ANS) in the symptomatology of Long COVID and demonstrated that patients with a Long COVID present a dysfunction of their ANS which is objectified by a reduced Heart Rate Variability (HRV). The regulation of heart rate by the ANS is strongly favored by respiration. A regular slow and deep breathing training helps to adjust the baroreflex, which connect heart rate, breathing and blood pressure. The result of this training is an induced state called "cardiac coherence" (CC).

The investigator therefore hypothesize that respiratory training to CC could "re-educate" the ANS and durably improve the symptomatology of patients with Long COVID.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

CHU de la Réunion, Saint-Denis, France

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients over the age of 18,
  • living in Reunion and
  • having a diagnosis of Long COVID according to the World Health Organization (WHO) definition will be included in this study.
  • These patients must attest to their primary infection with Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) and present a negative antigen test at the time of inclusion.

Exclusion criteria

Patients:

  • with a chronic or disabling respiratory pathology preventing respiratory training (asthma, Chronic Obstructive Pulmonary Disease (COPD), active tuberculosis, pulmonary sequelae of COVID-19, etc.) practicing or having practiced a regular respiratory control technique (yoga, Cardiac coherence training, etc.) in the last 6 months
  • taking a beta-blocker, betamimetic, anti-arrhythmic, morphine, antidepressant treatment (Escitalopram)
  • having a pacemaker or severe heart disease
  • Current and known pregnancy or breastfeeding woman
  • with a cognitive deficit
  • under guardianship/curators or under judicial protection

Treatment and study plan

Cardiac coherence

Other

Use of Cardiac coherence (complementary respiratory training) during 6 month

Primary outcomes

  1. Evaluation of the effectiveness of a respiratory training to cardiac coherence on the reduction in the symptomatology of patients with Long COVID.

    Time frame: 6 months

    mean score on the Long COVID Symptom Tool (ST) scale Score 0 to 53 / Higher score mean worse outcome

Secondary outcomes

  1. Evaluation of the effectiveness of a respiratory training to cardiac coherence on the decrease of overall symptoms over time

    Time frame: T0, 1 month, 2 months, 3 months, 6 months

    Long COVID Symptom Tool (ST) scale Score 0 to 53 / Higher score mean worse outcome

  2. Evaluation of the effectiveness of a respiratory training to cardiac coherence on the decrease of specifics symptoms : fatigue

    Time frame: 3 months, 6 months

    The 11-item Chalder Fatigue Scale (CFS-11) score 0 to 11 / Higher score mean worse outcome

  3. Evaluation of the effectiveness of a respiratory training to cardiac coherence on the decrease of specifics symptoms : dyspnoea

    Time frame: 3 months, 6 months

    Modified Medical Research Council (MMRC) dyspnoea scale score 0 to 5 / Higher score mean worse outcome

  4. Evaluation of the effectiveness of a respiratory training to cardiac coherence on the decrease of specifics symptoms : Anxiety and Depression

    Time frame: 3 months, 6 months

    Hospital Anxiety and Depression scale (HADS) Score 0 to 42 / Higher score mean worse outcome

  5. Evaluation of the effectiveness of a respiratory training to cardiac coherence on the decrease of specifics symptoms : cognitive disorders

    Time frame: 3 months, 6 months

    Montreal Cognitive Assessment (MoCA) Score 0 to 30 / Higher score mean better outcome

  6. Evaluation of the effectiveness of a respiratory training to cardiac coherence on the decrease of specifics symptoms : Post Traumatic Stress Disorder

    Time frame: 3 months, 6 months

    Posttraumatic Stress Disorder Checklist for Diagnostic and statistical manual of mental disorders, version 5 (PCL-5) Score 0 to 80 / Higher score mean worse outcome

  7. Evaluation of the effectiveness of a respiratory training to CC on the impact of the disease on daily life

    Time frame: T0, 1 month, 2 months, 3 months, 6 months

    Long COVID Impact Tool (IT) scale Score 0 to 60 / Higher score mean worse outcome

Study contacts

Contact information is provided by the study sponsor or research team.

Léa BRUNEAU

CONTACT

[email protected]

02 62 90 68 83 ext. +262

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Universitaire de la Réunion

Other

Registry information

Official study title

Randomized Controlled Trial Evaluating the Effectiveness of a Breathing Control Technique on Long COVID Symptoms at the Reunion University Hospital

Acronym: COCO-Long'Run

Important dates

Study start
2025
Primary completion
2026
Study completion
2027
First posted
May 10, 2023
Registry last updated
Jul 30, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.